Jacobs Levy Equity Management
TYRA icon

Jacobs Levy Equity Management’s Tyra Biosciences TYRA Stock Holding History

Jacobs Levy Equity Management’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.21M Buy
162,204
+32,451
+25% +$1.05M 0.03% 381
2025
Q4 		$3.41M Sell
129,753
-121,809
-48% -$2.24M 0.01% 488
2025
Q3 		$3.52M Sell
251,562
-143,737
-36% -$1.64M 0.01% 490
2025
Q2 		$3.78M Buy
395,299
+93,498
+31% +$888K 0.01% 503
2025
Q1 		$2.81M Buy
301,801
+57,556
+24% +$745K 0.01% 586
2024
Q4 		$3.4M Buy
+244,245
New +$4.43M 0.01% 498

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Jacobs Levy Equity Management's TYRA Position: Q1 2026 in Review

Jacobs Levy Equity Management increased its Tyra Biosciences (TYRA) stake by 25% in Q1 2026, buying an estimated $1.05M and bringing the position to 162,204 shares worth $6.21M. The position accounts for 0.03% of the portfolio, ranked #381.

Jacobs Levy Equity Management first reported a position in TYRA in Q4 2024 and has held it in 6 quarters since. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • Jacobs Levy Equity Management held 162,204 shares of Tyra Biosciences worth $6.21M as of Q1 2026.
  • Jacobs Levy Equity Management bought 32,451 Tyra Biosciences shares in Q1 2026, an estimated $1.05M.
  • Tyra Biosciences made up 0.03% of Jacobs Levy Equity Management's portfolio in Q1 2026, its #381 holding.
  • Jacobs Levy Equity Management first reported a position in Tyra Biosciences in Q4 2024 and has held it in 6 quarters since.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2026, filed 15 May 2026.